User profiles for Sevki S. Cetinkalp

Şevki Çetinkalp

Ege Üniversitesi Tıp Fakültesi
Verified email at ege.edu.tr
Cited by 2508

[HTML][HTML] Review of factors contributing to nodular goiter and thyroid carcinoma

I Yildirim Simsir, S Cetinkalp, T Kabalak - Medical Principles and …, 2020 - karger.com
… Scintigraphy is not a routine laboratory method for … is at the lower limit or is suppressed
further in an individual with nodular goiter, scintigraphy is used to assess whether the nodule is

Glucagon like peptide-1 (GLP-1) likes Alzheimer's disease

IY Simsir, UE Soyaltin, S Cetinkalp - Diabetes & Metabolic Syndrome …, 2018 - Elsevier
… Alzheimer’s disease (AD) is the most prevalent form of dementia. It is characterized by cognitive
… The pathophysiological relationship between GLP-1 and AD is discussed in this review. …

Insulin resistance in brain and possible therapeutic approaches

S Cetinkalp, IY Simsir, S Ertek - Current vascular …, 2014 - ingentaconnect.com
… Progressive brain insulin resistance and pancreatic insulin deficiency are observed in
Alzheimer’s disease (AD), and at the same time, T2DM is a significant risk factor for developing …

Efficacy of insulin-sensitizing agents in nonalcoholic fatty liver disease

Z Omer, S Cetinkalp, M Akyildiz, F Yilmaz… - European journal of …, 2010 - journals.lww.com
… (NAFLD) is one of the common liver diseases in the world. Although simple fatty liver is usually
considered a … The pathophysiology of NAFLD is defined by a ‘two-hit model’. The first hit …

[HTML][HTML] Streptozotocin-induced diabetic effects on spermatogenesis with proliferative cell nuclear antigen immunostaining of adult rat testis

B Altay, Ş Çetinkalp, B Doǧanavşargil, M Hekimgil… - Fertility and sterility, 2003 - Elsevier
… the S and G 2 phases of the cell cycle. It is only absent during the G 0 phase. PCNA has a
biological half-life of 20 hours. It is an auxillary protein of DNA polmerase-δ and is involved in …

Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis

L Kardeşler, N Buduneli, Ş Çetinkalp… - Journal of …, 2010 - Wiley Online Library
is possible that treating more severe periodontal disease is more effective in achieving
significant changes in HbA1c levels. Also, it is … the literature and it is possible that individuals with …

Fibroblast growth factor-19 levels in type 2 diabetic patients with metabolic syndrome

…, G Basol, Y Cakir, S Cetinkalp… - Annals of Clinical & …, 2011 - Assoc Clin Scientists
… Atherogenic dyslipidemia is generally characterized by increased plasma TG and decreased
HDL-c. Since the major focus is on the connection between lipids and coronary heart …

Demographic, clinical, laboratory, ultrasonographic, and cytological features of patients with Hashimoto's thyroiditis: results of a university hospital of 769 patients in …

M Erdogan, N Erdem, S Cetinkalp, AG Ozgen, F Saygılı… - Endocrine, 2009 - Springer
We investigated the demographic and clinical features of patients with Hashimoto’s thyroiditis
who had been diagnosed and treated in Ege University, the main referral center in the …

Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

…, S Cetinkalp, H Ozisik, GG Oruk, S Yener… - Diabetes research and …, 2018 - Elsevier
Aims Turkey has the highest prevalence of diabetes in Europe. It is therefore essential to
know the overall cardiovascular risk and reveal the predictors of metabolic control in Turkish …

Gingival crevicular fluid PGE2, IL-1ß, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease

L Kardeşler, N Buduneli, B Bıyıkoğlu, Ş Çetinkalp… - Clinical …, 2008 - Elsevier
… The plasminogen activating system is known to be associated with fibrinolysis and, thereby
it is of central importance in extracellular matrix (ECM) degradation and remodelling. Plasmin …